Penggunaan Ganja Medis Dalam Pengobatan Rasional Dan Pengaturannya di Indonesia

Nur Arfiani; Indah Woro Utami

doi:10.30649/jhek.v2i1.45

Authors

Nur Arfiani Universitas Mulia
Indah Woro Utami Universitas Mulia

DOI:

https://doi.org/10.30649/jhek.v2i1.45

Keywords:

Medical Marijuana, Rational Medication, Regulation

Abstract

Medical marijuana (Cannabis sativa) has been used since ancient time. Its use is written in medical books from china, india and even the Mesopotamian era. In these records, the use of marijuana (Cannabis sativa) is not only as a medicine, but also as a food ingredient and a ritual tool. A popular issue in Indonesia today is about legalization of medical marijuana. Marijuana is a class I narcotic which is written in the law. Cannabis has a very high potential to cause addicted and not used for therapy. However, several institutions have discussed that marijuana can be legalized in Indonesia. Cannabis can provide health benefits and has economic potential. Marijuana countains cannabinoids that are considered to have medical benefits. Several countries have developed marijuana into legal medicinal preparations. Economically, medical marijuana has great potential as an export commodity. The approach in this study uses a qualitative method by using data from books, regulations, expert opinions, as well as examining various scientific journal using Garuda, PubMed, Sciencedirect, and Wiley. The result of data analysis is in the form of systematic information. This article can be a reference for development and legalization of medical marijuana in Indonesia.

References

Peraturan Perundang-Undangan:

Undang-Undang Nomor 35 tahun 2009 tentang Narkotika

Undang-Undang Nomor 13 Tahun 2020 tentang Hortikultura

Undang-Undang Nomor 36 Tahun 2009 tentang Kesehatan

Keputusan Menteri Pertanian Republik Indonesia Nomor.104/KPTS/HK.140/M/2/2020 tentang Komoditas Binaan Kementerian Pertanian

Buku:

American Herbal Pharmacopeia. (2020). Cannabis Inflorescence Quality Control Monograph. CRC Press.

Asyhadie, Zaeni, dan Arief Rahman. (2019). Pengantar Ilmu Hukum. Depok: Rajawali Press

Darmawan, M. Kemal. (2019). Teori Kriminologi. Tangerang: Universitas Terbuka

Diantha, I Made Pasek. (2019). Metodologi Penelitian Hukum Normatif dalam Justifikasi Teori Hukum, Jakarta: Kencana, Prenada Media Group

Dirdjosisworo, Soedjono, (2019). Pengantar Ilmu Hukum. Depok: Rajawali Press

Effendi, Djoenaedi dan Johnny Ibrahim (2020). Metode Penelitian Hukum Normatif dan Empiris, Jakarta: Kencana, Prenada Media Group

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2018). Medical Use of Cannabis and Cannabinoid. Luxembourg: Publications Office of the European Union

Iskandar, Anang. (2019). Penegakkan Hukum Narkotika.Jakarta: PT. Elex Media Komputindo

Lilik Mulyadi (2007). Kapita Selekta Hukum Pidana Kriminologi dan Viktimologi, Denpasar: Djambatan.

Marzuki, Peter Mahmud. (2019). Penelitian Hukum. Jakarta: Kencana, Prenada Media Group

Nasution, Bahder Johan/. (2008). Metode Penelitian Hukum. Bandung: Mandar Maju.

Nazir, Moh. (2014). Metode Penelitian, Jakarta: Ghalia Indonesia.

Siswati, Sri. (2013). Etika dan Hukum Kesehatan dalam Perspektif Undang-Undang Kesehatan, Jakarta: Raja Grafindo Persada

Soekanto, Soerjono. (2004). Penelitian Hukum Normatif. Jakarta: PT. Raja Grafindo Persada.

Widagdo, Setyo, dkk. (2019). Hukum Internasional dalam Dinamika Hubungan Internasional, Malang; UB Press.

Jurnal:

Alison C Burggren, et.al., (2019). Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abuse. 45(6): 563–579. doi: http://doi: 10.1080/00952990.2019.1634086

Bridgeman, M. B., & Abazia, D. T. (2017). Medicinal cannabis: History, pharmacology, and implications for the acute care setting. P & T: A Peer-Reviewed Journal for Formulary Management, 42(3).

Christopher A. Legare. et.al., (2022). Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Pharmacology 2022;107:131–149 doi: http://doi: 10.1159/000521683

Emily Stockings. et.al., (2018). Evidence for cannabis and cannabinoids for epilepsy: A systematic review of controlled and observational evidence. Journal of Neurology, Neurosurgery, and Psychiatry 89:7 doi: http://doi:10.1136/jnnp-2017-317168

Herman Johal. et.al., (2020). Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders Volume 13: 1–13 doi: https://doi.org/10.1177/1179544120906461

Keane Lim, et.al., (2017). A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders. Clinical Psychopharmacology and Neuroscience 15(4):301-312. doi: http://doi: 10.9758/cpn.2017.15.4.301

Massot-Tarrus A & McLachlan RS. (2017). Marijuana use in adults admitted to a Canadian epilepsy monitoring unit. Epilepsy & Behavior. [PubMed] 63:73–78. doi: http://doi:10.1016/j.yebeh.2016.08.002.

Pierre-Arnaud Chouvy. (2019). Cannabis cultivation in the world: heritages, trends and challenges. Echogeo 48: 2-3. doi: https://doi.org/10.4000/echogeo.17591

Stevie Britch, et.al., (2021). Cannabidiol: pharmacology and therapeutic targets Psychopharmacology 238(Suppl 1):1-20. doi: http://doi:10.1007/s00213-020-05712-8

Suman Chandra, et.al., (2019). New trends in cannabis potency in USA and Europe during the last decade (2008–2017). European Archives of Psychiatry and Clinical Neuroscience 269:5–15. doi: https://doi.org/10.1007/s00406-019-00983-5

William Beedham. et.al., (2020). Cannabinoids in the Older Person: A Literature Review. Geriatrics 5:2 doi: http://doi:10.3390/geriatrics5010002